
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Chris Robinson is currently the Director of Pain and Headache Rounds at Harvard-Massachusetts General Hospital. He is also a Section Editor with the Journal of Pain Research and a committee member of the American Society of Pain and Neuroscience.

With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.

In a third installment of our interview series with Chris Robinson, MD, PhD, we looked at the future of pain management and emerging technologies being used for treatment.

Chris Robinson, MD, PhD, joined Drug Topics to discuss the importance of education in newly explored technologies for the treatment of pain.

Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.

Published: March 13th 2025 | Updated:

Published: March 5th 2025 | Updated: